课题基金 / 基金详情

The investigation of new treatment for ovarian clear cell carcinoma with TOP2A amplification

The investigation of new treatment for ovarian clear cell carcinoma with TOP2A amplification
TOP2A扩增治疗卵巢透明细胞癌新疗法的研究
批准号:
16H06907
负责人:
Murakami Ryusuke
金额:
$1.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-08-26 至 2018-03-31

项目摘要

项目成果

Murakami Ryusuke的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2017
期刊:
影响因子: --
作者: [Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai]
通讯作者: Masaki Mandai
Is the mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin (ddTC) than to conventional taxane and carboplatin chemotherapy (TC) in high grade serous ovarian carcinoma? A survey of Japanese Gynecology
在高级别浆液性卵巢癌中,间充质转化亚型对剂量密集紫杉烷化疗联合卡铂 (ddTC) 的反应是否比传统紫杉烷和卡铂化疗 (TC) 更敏感?
DOI: --
发表时间: 2017
期刊:
影响因子: --
作者: [Ryusuke Murakami, Noriomi Matsumura, Hiroshi Tanabe, Hirofumi Michimae, Mayu Yunokawa, Haruko Iwase, Motoi Sasagawa, Toshiaki Nakamura, Osamu Tokuyama, Masashi Takano, Toru Sugiyama, Takashi Sawasaki, Seiji Isonishi, Kazuhiro Takehara, Hidekatsu Nakai, Ai]
通讯作者: Ai
DOI: --
发表时间: 2016
期刊:
影响因子: --
作者: [Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura]
通讯作者: Noriomi Matsumura
Therapeutic development targeting B7H3 in the tumor microenvironment of ovarian cancer
  • 批准号:
    20K18210
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
  • 资助金额:
    $2.75万
  • 财政年份:
    2020
  • 负责人:
    Murakami Ryusuke
  • 依托单位:
Development of personalized treatment by stratification targeting the microenvironment of ovarian cancer